Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-(2-propenyl)-2'-deoxyuridine is a modified nucleoside characterized by the presence of a propenyl group at the 5-position of the uracil ring. It is a key component in the synthesis of nucleic acid analogs, primarily utilized for research purposes. 5-(2-propenyl)-2'-deoxyuridine has garnered attention for its potential antiviral and antitumor properties, attributed to its capacity to inhibit both DNA and RNA synthesis. Furthermore, it has been explored for applications in gene therapy and as a radiosensitizer in cancer treatment, highlighting its significance in medicinal chemistry and drug discovery.

73-39-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 73-39-2 Structure
  • Basic information

    1. Product Name: 5-(2-propenyl)-2'-deoxyuridine
    2. Synonyms: 5-(2-propenyl)-2'-deoxyuridine;2'-Deoxy-5-(2-propenyl)uridine;5-Allyl-2'-deoxyuridine;5-Allyldeoxyuridine
    3. CAS NO:73-39-2
    4. Molecular Formula: C12H16N2O5
    5. Molecular Weight: 0
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 73-39-2.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.368g/cm3
    6. Refractive Index: 1.575
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 9.42±0.10(Predicted)
    10. CAS DataBase Reference: 5-(2-propenyl)-2'-deoxyuridine(CAS DataBase Reference)
    11. NIST Chemistry Reference: 5-(2-propenyl)-2'-deoxyuridine(73-39-2)
    12. EPA Substance Registry System: 5-(2-propenyl)-2'-deoxyuridine(73-39-2)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 73-39-2(Hazardous Substances Data)

73-39-2 Usage

Uses

Used in Pharmaceutical Research:
5-(2-propenyl)-2'-deoxyuridine is used as a research compound for the synthesis of nucleic acid analogs, facilitating the study of their structure, function, and potential therapeutic applications.
Used in Antiviral Applications:
In the field of virology, 5-(2-propenyl)-2'-deoxyuridine is used as an antiviral agent due to its ability to inhibit viral DNA and RNA synthesis, thereby potentially limiting the replication and spread of viruses.
Used in Antitumor Applications:
5-(2-propenyl)-2'-deoxyuridine is utilized as an antitumor agent, leveraging its capacity to inhibit nucleic acid synthesis in tumor cells, which may contribute to the suppression of tumor growth and progression.
Used in Gene Therapy:
5-(2-propenyl)-2'-deoxyuridine is employed as a component in gene therapy strategies, where its unique structure may be harnessed to modulate gene expression or correct genetic defects, offering a potential avenue for treating genetic disorders.
Used as a Radiosensitizer in Cancer Treatment:
In oncology, 5-(2-propenyl)-2'-deoxyuridine is used as a radiosensitizer to enhance the effectiveness of radiation therapy in cancer treatment, potentially increasing the sensitivity of cancer cells to radiation and improving treatment outcomes.
Used in Medicinal Chemistry and Drug Discovery:
5-(2-propenyl)-2'-deoxyuridine is utilized as a valuable compound in the field of medicinal chemistry for further research and development, given its unique structure and potential biological applications, which may lead to the discovery of new drugs and therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 73-39-2 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 7 and 3 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 73-39:
(4*7)+(3*3)+(2*3)+(1*9)=52
52 % 10 = 2
So 73-39-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H16N2O5/c1-2-3-7-5-14(12(18)13-11(7)17)10-4-8(16)9(6-15)19-10/h2,5,8-10,15-16H,1,3-4,6H2,(H,13,17,18)

73-39-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Uridine, 5-allyl-2'-deoxy-

1.2 Other means of identification

Product number -
Other names 5-Allyl-2'-deoxyuridin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:73-39-2 SDS

73-39-2Synthetic route

methanol
67-56-1

methanol

C5-chloromercuri-2'-deoxyuridine
65505-76-2

C5-chloromercuri-2'-deoxyuridine

3-chloroprop-1-ene
107-05-1

3-chloroprop-1-ene

A

(E)-5-<3-(2'-deoxyuridylin-5-yl)-1-propen-1-yl>-2'-deoxyuridine
76334-41-3

(E)-5-<3-(2'-deoxyuridylin-5-yl)-1-propen-1-yl>-2'-deoxyuridine

B

5-<3-(2'-deoxyuridin-5-yl)-1-methoxyprop-1-yl>-2'-deoxyuridine
76334-42-4

5-<3-(2'-deoxyuridin-5-yl)-1-methoxyprop-1-yl>-2'-deoxyuridine

C

C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

Conditions
ConditionsYield
With lithium tetrachloropalladate(II) Yield given;A n/a
B n/a
C 84%
C5-chloromercuri-2'-deoxyuridine
65505-76-2

C5-chloromercuri-2'-deoxyuridine

3-chloroprop-1-ene
107-05-1

3-chloroprop-1-ene

A

(E)-5-<3-(2'-deoxyuridylin-5-yl)-1-propen-1-yl>-2'-deoxyuridine
76334-41-3

(E)-5-<3-(2'-deoxyuridylin-5-yl)-1-propen-1-yl>-2'-deoxyuridine

B

5-<3-(2'-deoxyuridin-5-yl)-1-methoxyprop-1-yl>-2'-deoxyuridine
76334-42-4

5-<3-(2'-deoxyuridin-5-yl)-1-methoxyprop-1-yl>-2'-deoxyuridine

C

C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

Conditions
ConditionsYield
With lithium tetrachloropalladate(II) In methanolA n/a
B n/a
C 84%
C5-chloromercuri-2'-deoxyuridine
65505-76-2

C5-chloromercuri-2'-deoxyuridine

3-chloroprop-1-ene
107-05-1

3-chloroprop-1-ene

C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

Conditions
ConditionsYield
With palladium dichloride In methanol for 20h;78%
lithium tetrachloropalladate(II) In methanol
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

allyl-trimethyl-silane
762-72-1

allyl-trimethyl-silane

A

2'-deoxyuridine
951-78-0

2'-deoxyuridine

B

C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

Conditions
ConditionsYield
In water; acetonitrile Irradiation;A 31%
B 49%
In water; acetonitrile for 10h; Ambient temperature; Irradiation;A 31%
B 49%
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

A

2'-deoxyuridine
951-78-0

2'-deoxyuridine

B

C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

Conditions
ConditionsYield
With allyl-trimethyl-silane In water; acetonitrile Irradiation;A 31%
B 49%
With allyl-trimethyl-silane In water; acetonitrile for 10h; Ambient temperature; Irradiation;A 31%
B 49%
methanol
67-56-1

methanol

3-ethoxyprop-1-ene
557-31-3

3-ethoxyprop-1-ene

C5-chloromercuri-2'-deoxyuridine
65505-76-2

C5-chloromercuri-2'-deoxyuridine

A

5-(2,2-dimethoxy-1-methylethyl)-2'-deoxyuridine
76334-65-1

5-(2,2-dimethoxy-1-methylethyl)-2'-deoxyuridine

B

C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

Conditions
ConditionsYield
With lithium tetrachloropalladate(II)A 15%
B 32%
3-ethoxyprop-1-ene
557-31-3

3-ethoxyprop-1-ene

C5-chloromercuri-2'-deoxyuridine
65505-76-2

C5-chloromercuri-2'-deoxyuridine

A

5-(2,2-dimethoxy-1-methylethyl)-2'-deoxyuridine
76334-65-1

5-(2,2-dimethoxy-1-methylethyl)-2'-deoxyuridine

B

C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

Conditions
ConditionsYield
With lithium tetrachloropalladate(II) In methanolA 15%
B 32%
5-Iodo-2'-deoxyuridine
54-42-2

5-Iodo-2'-deoxyuridine

allyltributylstanane
24850-33-7

allyltributylstanane

C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

Conditions
ConditionsYield
With bis-triphenylphosphine-palladium(II) chloride In tetrahydrofuran for 24h; Heating; Yield given;
4,4'-dimethoxytrityl chloride
40615-36-9

4,4'-dimethoxytrityl chloride

C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

5-allyl-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)uridine
809290-35-5

5-allyl-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)uridine

Conditions
ConditionsYield
Stage #1: C5-(allyl)-2'-deoxyuridine With pyridine; silver nitrate for 0.0833333h;
Stage #2: 4,4'-dimethoxytrityl chloride for 4h;
86%
With pyridine; silver nitrate
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

3',5'-bis-O-(tert-butyldimethylsilyl)-C5-(allyl)-2'-deoxyuridine
151894-33-6

3',5'-bis-O-(tert-butyldimethylsilyl)-C5-(allyl)-2'-deoxyuridine

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide for 3h;78%
With 1H-imidazole In N,N-dimethyl-formamide Yield given;
1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane
69304-37-6

1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane

C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

5-Allyl-1-((2R,3aS,9aR)-5,5,7,7-tetraisopropyl-tetrahydro-1,4,6,8-tetraoxa-5,7-disila-cyclopentacycloocten-2-yl)-1H-pyrimidine-2,4-dione
194595-63-6

5-Allyl-1-((2R,3aS,9aR)-5,5,7,7-tetraisopropyl-tetrahydro-1,4,6,8-tetraoxa-5,7-disila-cyclopentacycloocten-2-yl)-1H-pyrimidine-2,4-dione

Conditions
ConditionsYield
In pyridine at 0℃;68%
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

5-allyl-5'-O-tert-butyldimethylsilyl-2'-deoxyuridine
809290-37-7

5-allyl-5'-O-tert-butyldimethylsilyl-2'-deoxyuridine

Conditions
ConditionsYield
Stage #1: C5-(allyl)-2'-deoxyuridine With pyridine; silver nitrate for 0.0833333h;
Stage #2: tert-butyldimethylsilyl chloride for 10h;
42%
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

5-Propyl-2'-deoxyuridine
27826-74-0

5-Propyl-2'-deoxyuridine

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In methanol under 1241.2 Torr; for 10h;
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

5-allyl-5'-O-(tert-butyldimethylsilyl)-2'-deoxyuridine-3'-O-{(N,N-diisopropyl)-(2-cyanoethyl)phosphoramidite}
809290-38-8

5-allyl-5'-O-(tert-butyldimethylsilyl)-2'-deoxyuridine-3'-O-{(N,N-diisopropyl)-(2-cyanoethyl)phosphoramidite}

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 42 percent / 10 h
2.1: 75 percent / 4,5-dicyanoimidazole / CH2Cl2; acetonitrile / 0.58 h / 20 °C
View Scheme
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

C35H57N4O12PSi2
809290-46-8

C35H57N4O12PSi2

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 86 percent / 4 h
2.1: 86 percent / pyridine; AgNO3 / 0.08 h
3.1: 88 percent / p-toluenesulfonic acid monohydrate / methanol; CH2Cl2 / 0.58 h / 0 °C
4.1: 1H-tetrazole / acetonitrile / 1.5 h / 20 °C
4.2: 64 percent / t-BuOOH / acetonitrile; toluene / 1.5 h
5.1: 58 percent / (1,3-dimesitylimidazolidin-2-ylidene)[(c-hexyl)3P]Cl2Ru=CHPh / CH2Cl2 / 2 h / Heating
View Scheme
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

C37H58N5O12PSi2

C37H58N5O12PSi2

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 86 percent / 4 h
2.1: 86 percent / pyridine; AgNO3 / 0.08 h
3.1: 88 percent / p-toluenesulfonic acid monohydrate / methanol; CH2Cl2 / 0.58 h / 0 °C
4.1: 1H-tetrazole / acetonitrile / 0.5 h
5.1: 0.142 g / t-BuOOH / acetonitrile; toluene / 2 h
6.1: 27 percent / (1,3-dimesitylimidazolidin-2-ylidene)[(c-hexyl)3P]Cl2Ru=CHPh / CH2Cl2 / 22 h / Heating
View Scheme
Multi-step reaction with 5 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 42 percent / 10 h
2.1: 75 percent / 4,5-dicyanoimidazole / CH2Cl2; acetonitrile / 0.58 h / 20 °C
3.1: 1H-tetrazole / acetonitrile / 0.5 h
4.1: 0.142 g / t-BuOOH / acetonitrile; toluene / 2 h
5.1: 27 percent / (1,3-dimesitylimidazolidin-2-ylidene)[(c-hexyl)3P]Cl2Ru=CHPh / CH2Cl2 / 22 h / Heating
View Scheme
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

C39H62N5O11PSi2

C39H62N5O11PSi2

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 86 percent / 4 h
2.1: 86 percent / pyridine; AgNO3 / 0.08 h
3.1: 88 percent / p-toluenesulfonic acid monohydrate / methanol; CH2Cl2 / 0.58 h / 0 °C
4.1: 1H-tetrazole / acetonitrile / 0.5 h
View Scheme
Multi-step reaction with 3 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 42 percent / 10 h
2.1: 75 percent / 4,5-dicyanoimidazole / CH2Cl2; acetonitrile / 0.58 h / 20 °C
3.1: 1H-tetrazole / acetonitrile / 0.5 h
View Scheme
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

C39H62N5O12PSi2

C39H62N5O12PSi2

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 86 percent / 4 h
2.1: 86 percent / pyridine; AgNO3 / 0.08 h
3.1: 88 percent / p-toluenesulfonic acid monohydrate / methanol; CH2Cl2 / 0.58 h / 0 °C
4.1: 1H-tetrazole / CH2Cl2; acetonitrile / 1 h
View Scheme
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

C39H62N5O13PSi2

C39H62N5O13PSi2

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 86 percent / 4 h
2.1: 86 percent / pyridine; AgNO3 / 0.08 h
3.1: 88 percent / p-toluenesulfonic acid monohydrate / methanol; CH2Cl2 / 0.58 h / 0 °C
4.1: 1H-tetrazole / CH2Cl2; acetonitrile / 1 h
5.1: 0.156 g / t-BuOOH / CH2Cl2; acetonitrile; toluene / 3 h / 0 - 20 °C
View Scheme
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

C39H62N5O12PSi2
809290-45-7

C39H62N5O12PSi2

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 86 percent / 4 h
2.1: 86 percent / pyridine; AgNO3 / 0.08 h
3.1: 88 percent / p-toluenesulfonic acid monohydrate / methanol; CH2Cl2 / 0.58 h / 0 °C
4.1: 1H-tetrazole / acetonitrile / 0.5 h
5.1: 0.142 g / t-BuOOH / acetonitrile; toluene / 2 h
View Scheme
Multi-step reaction with 4 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 42 percent / 10 h
2.1: 75 percent / 4,5-dicyanoimidazole / CH2Cl2; acetonitrile / 0.58 h / 20 °C
3.1: 1H-tetrazole / acetonitrile / 0.5 h
4.1: 0.142 g / t-BuOOH / acetonitrile; toluene / 2 h
View Scheme
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

5-allyl-3'-O-tert-butyldimethylsilyl-2'-deoxyuridine
492452-95-6

5-allyl-3'-O-tert-butyldimethylsilyl-2'-deoxyuridine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 86 percent / 4 h
2.1: 86 percent / pyridine; AgNO3 / 0.08 h
3.1: 88 percent / p-toluenesulfonic acid monohydrate / methanol; CH2Cl2 / 0.58 h / 0 °C
View Scheme
Multi-step reaction with 3 steps
1: AgNO3; pyridine
2: AgNO3; pyridine
3: p-TsOH / CH2Cl2; methanol / 0 °C
View Scheme
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

5-allyl-3'-O-tert-butyldimethylsilyl-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)uridine
809290-36-6

5-allyl-3'-O-tert-butyldimethylsilyl-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)uridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 86 percent / 4 h
2.1: 86 percent / pyridine; AgNO3 / 0.08 h
View Scheme
Multi-step reaction with 2 steps
1: AgNO3; pyridine
2: AgNO3; pyridine
View Scheme
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

(2R,4S,5R)-4-Hydroxy-8-[(2R,3S,5R)-2-hydroxymethyl-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yloxy]-8-oxo-7,9,19-trioxa-1,16-diaza-8λ5-phospha-tricyclo[12.3.1.12,5]nonadec-14(18)-ene-15,17-dione
492453-06-2

(2R,4S,5R)-4-Hydroxy-8-[(2R,3S,5R)-2-hydroxymethyl-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yloxy]-8-oxo-7,9,19-trioxa-1,16-diaza-8λ5-phospha-tricyclo[12.3.1.12,5]nonadec-14(18)-ene-15,17-dione

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 86 percent / 4 h
2.1: 86 percent / pyridine; AgNO3 / 0.08 h
3.1: 88 percent / p-toluenesulfonic acid monohydrate / methanol; CH2Cl2 / 0.58 h / 0 °C
4.1: 1H-tetrazole / acetonitrile / 1.5 h / 20 °C
4.2: 64 percent / t-BuOOH / acetonitrile; toluene / 1.5 h
5.1: (1,3-dimesitylimidazolidin-2-ylidene)[(c-hexyl)3P]Cl2Ru=CHPh / CH2Cl2 / 3.5 h / Heating
5.2: 63 percent / H2 / CH2Cl2 / 50 °C / 51714.8 Torr
6.1: 100 percent / trifluoroacetic acid / H2O / 3 h
View Scheme
Multi-step reaction with 7 steps
1.1: AgNO3; pyridine
2.1: AgNO3; pyridine
3.1: p-TsOH / CH2Cl2; methanol / 0 °C
4.1: 1H-tetrazole / acetonitrile
5.1: tert-BuOOH / acetonitrile
6.1: Grubbs' type catalyst / CH2Cl2 / 40 °C
6.2: 63 percent / H2 / Grubbs' type catalyst / CH2Cl2 / 50 °C / 51716.2 Torr
7.1: 100 percent / aq. TFA
View Scheme
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

Phosphoric acid (2R,3S,5R)-5-[5-((E)-4-amino-but-2-enyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-3-hydroxy-tetrahydro-furan-2-ylmethyl ester (2R,3S,5R)-2-hydroxymethyl-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester

Phosphoric acid (2R,3S,5R)-5-[5-((E)-4-amino-but-2-enyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-3-hydroxy-tetrahydro-furan-2-ylmethyl ester (2R,3S,5R)-2-hydroxymethyl-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 86 percent / 4 h
2.1: 86 percent / pyridine; AgNO3 / 0.08 h
3.1: 88 percent / p-toluenesulfonic acid monohydrate / methanol; CH2Cl2 / 0.58 h / 0 °C
4.1: 1H-tetrazole / acetonitrile / 1.5 h / 20 °C
4.2: 64 percent / t-BuOOH / acetonitrile; toluene / 1.5 h
5.1: 58 percent / (1,3-dimesitylimidazolidin-2-ylidene)[(c-hexyl)3P]Cl2Ru=CHPh / CH2Cl2 / 2 h / Heating
6.1: NH3 / H2O / 24 h / 20 °C
View Scheme
Multi-step reaction with 7 steps
1: AgNO3; pyridine
2: AgNO3; pyridine
3: p-TsOH / CH2Cl2; methanol / 0 °C
4: 1H-tetrazole / acetonitrile
5: tert-BuOOH / acetonitrile
6: 58 percent / Grubbs' type catalyst / CH2Cl2 / 40 °C
7: 100 percent / aq. NH3 / 55 °C
View Scheme
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

C35H59N4O12PSi2
492453-05-1

C35H59N4O12PSi2

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 86 percent / 4 h
2.1: 86 percent / pyridine; AgNO3 / 0.08 h
3.1: 88 percent / p-toluenesulfonic acid monohydrate / methanol; CH2Cl2 / 0.58 h / 0 °C
4.1: 1H-tetrazole / acetonitrile / 1.5 h / 20 °C
4.2: 64 percent / t-BuOOH / acetonitrile; toluene / 1.5 h
5.1: (1,3-dimesitylimidazolidin-2-ylidene)[(c-hexyl)3P]Cl2Ru=CHPh / CH2Cl2 / 3.5 h / Heating
5.2: 63 percent / H2 / CH2Cl2 / 50 °C / 51714.8 Torr
View Scheme
Multi-step reaction with 6 steps
1.1: AgNO3; pyridine
2.1: AgNO3; pyridine
3.1: p-TsOH / CH2Cl2; methanol / 0 °C
4.1: 1H-tetrazole / acetonitrile
5.1: tert-BuOOH / acetonitrile
6.1: Grubbs' type catalyst / CH2Cl2 / 40 °C
6.2: 63 percent / H2 / Grubbs' type catalyst / CH2Cl2 / 50 °C / 51716.2 Torr
View Scheme
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

C37H61N4O12PSi2
492452-96-7

C37H61N4O12PSi2

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: pyridine; AgNO3 / 0.08 h
1.2: 86 percent / 4 h
2.1: 86 percent / pyridine; AgNO3 / 0.08 h
3.1: 88 percent / p-toluenesulfonic acid monohydrate / methanol; CH2Cl2 / 0.58 h / 0 °C
4.1: 1H-tetrazole / acetonitrile / 1.5 h / 20 °C
4.2: 64 percent / t-BuOOH / acetonitrile; toluene / 1.5 h
View Scheme
Multi-step reaction with 5 steps
1: AgNO3; pyridine
2: AgNO3; pyridine
3: p-TsOH / CH2Cl2; methanol / 0 °C
4: 1H-tetrazole / acetonitrile
5: tert-BuOOH / acetonitrile
View Scheme
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

C35H57N4O12PSi2
492452-99-0

C35H57N4O12PSi2

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: AgNO3; pyridine
2: AgNO3; pyridine
3: p-TsOH / CH2Cl2; methanol / 0 °C
4: 1H-tetrazole / acetonitrile
5: tert-BuOOH / acetonitrile
6: 58 percent / Grubbs' type catalyst / CH2Cl2 / 40 °C
View Scheme
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

C37H61N4O11PSi2

C37H61N4O11PSi2

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: AgNO3; pyridine
2: AgNO3; pyridine
3: p-TsOH / CH2Cl2; methanol / 0 °C
4: 1H-tetrazole / acetonitrile
View Scheme
C5-(allyl)-2'-deoxyuridine
73-39-2

C5-(allyl)-2'-deoxyuridine

[2,4-Dioxo-1-((2R,3aS,9aR)-5,5,7,7-tetraisopropyl-tetrahydro-1,4,6,8-tetraoxa-5,7-disila-cyclopentacycloocten-2-yl)-1,2,3,4-tetrahydro-pyrimidin-5-yl]-acetaldehyde
194595-69-2

[2,4-Dioxo-1-((2R,3aS,9aR)-5,5,7,7-tetraisopropyl-tetrahydro-1,4,6,8-tetraoxa-5,7-disila-cyclopentacycloocten-2-yl)-1,2,3,4-tetrahydro-pyrimidin-5-yl]-acetaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: 68 percent / pyridine / 0 °C
2.1: K2OsO4*2H2O; N-methylmorpholino-N-oxide / acetone
2.2: NaIO4 / tetrahydrofuran; H2O
View Scheme

73-39-2Downstream Products

73-39-2Relevant articles and documents

Structure and dynamics of disulfide cross-linked DNA triple helices

Osborne, Scott E.,Cain, Robert J.,Glick, Gary D.

, p. 1171 - 1182 (2007/10/03)

The design, synthesis, and characterization of two disulfide cross-linked intramolecular pyr·pur-pyr triple helices (IV and V) is presented. Placement of a covalent cross-link from the Hoogsteen strand to the Watson-Crick duplex produces two fundamental changes in the cross-linked DNAs relative to the parent sequence. First, formation of the cross-link results in an increase in the apparent pK(a) of the Hoogsteen cytosines by 1.5 pK(a) units (to 8.6 and 8.3 for IV and V, respectively) with a concomitant increase in thermal stability of ~40°C at pH 7.4. Second, the cross-link enforces the triplex structure over a wide range of solution conditions, including those that are physiologically relevant (e.g., pH 7.4, 155 mM Na+, 37°C). CD and NMR measurements indicate that the cross-link does not significantly perturb the geometry of IV and V relative to their unmodified counterpart. Because the disulfide crosslink effectively prevents conformational heterogeneity associated with pyr·pur-pyr triple helices containing C+·G-C base-triplets at neutral pH, constructs possessing this modification can serve as model systems to examine the structural and thermodynamic aspects of triplex formation in vitro and to aid in the development of sequences that bind with higher affinity and specificity.

Incorporation of Alkylthiol Chains at C-5 of Deoxyuridine

Goodwin, Jay T.,Glick, Gary D.

, p. 5549 - 5552 (2007/10/02)

A series of alkylthiol-tether homologs at C-5 of 2'deoxyuridine have been synthetized and incorporated into DNA oligomers through solid-phase DNA phosphoramidite synthesis.DNA-ligand disulfide crosslinks have been initially addressed through formation of an n-butyl-DNA disulfide conjugate.

PALLADIUM-CATALYZED CROSS-COUPLING REACTION OF ORGANOSTANNANES WITH NUCLEOSIDE HALIDES

Hassan, Mohamed Ezeldin

, p. 1944 - 1948 (2007/10/02)

A general reaction is described for the synthesis of C-5 substituted nucleosides through the coupling of organostannanes with nucleoside-palladium intermediate derived in situ from 5-iodouridine (or 5-iodo-2'-deoxyuridine) and .The reaction was used for the synthesis of C-5 aryl, heteroaryl, vinyl, allyl and alkyl substituted nucleosides.

Photochemistry of 5- and 6-Iodouracils in the Presence of Allylsilanes and Alkenes. A Convenient Route to C5- and C6-Substituted Uracils

Saito, Isao,Ikehira, Hideyuki,Matsuura, Teruo

, p. 5148 - 5153 (2007/10/02)

The photocoupling reaction of 5- and 6-iodouracil derivatives with allylsilanes and alkenes is presented.Irradiation of 5-iodouridine (5) and 5-iodo-2'-deoxyuridine (6) in the presence of allyltrimethylsilane in aqueous acetonitrile gave 5-allyluridine (7) and 5-allyl-2'-deoxyuridine, respectively.Irradiation of 6-iodo-1,3-dimethyluracil (11) in the presence of allylsilanes and alkyl-substituted olefins produced the corresponding C6-substituted uracil derivatives in good yields. 5-Fluoro-6-iodo-1,3-dimethyluracil (12) underwent a similar photocoupling reaction with allylsilanes and alkenes.The photocoupling reaction provides a convenient method for carbon-carbon bond formation at the C5 or C6 position of uracil derivatives.A radical addition mechanism has been proposed for this novel photocoupling reaction.

A FACILE PHOTOCHEMICAL ROUTE TO C-5 AND C-6 ALLYL-SUBSTITUTED URACIL NUCLEOSIDES

Saito, Isao,Ikehira, Hideyuki,Matsuura, Teruo

, p. 1993 - 1994 (2007/10/02)

Irradiation of 5-iodouridine or 6-iodo-1,3-dimethyluracil in aq. acetonitrile in the presence of allyltrimethylsilane provided the corresponding 5- or 6-allylated product.

Structural requirements of olefinic 5-substituted deoxyuridines for antiherpes activity

Goodchild,Porter,Raper,Sim,Upton,Viney,Wadsworth

, p. 1252 - 1257 (2007/10/02)

A number of structurally related 5-substituted pyrimidine 2'-deoxyrubinucleosides were synthesized and tested for antiviral activity against herpes simplex virus type 1 (HSV-1) in cell culture. A minimum inhibitory concentration was determined for each compound, and from a comparison of these values a number of conclusions were drawn with regard to those molecular features that enhance or reduce antiviral activity. Optimum inhibition of HSV-1 in cell culture occurred when the 5-substituent was unsaturated and conjugated with the pyrimidine ring, was not longer than four carbon atoms in length, had E stereochemistry, and included a hydrophobic, electronegative function but did not contain a branching point. Such features are contained in (E)-5-(2-bromovinyl)-2'-deoxyuridine, which was the most active of the compounds described.

C-5-Substituted Pyrimidine Nucleosides. 3. Reaction of Allylic Chlorides, Alcohols, and Acetates with Pyrimidine Nucleoside Derived Organopalladium Intermediates

Bergstrom, Donald E.,Ruth, Jerry L.,Warwick, Paul

, p. 1432 - 1441 (2007/10/02)

The reaction of allylic chlorides with pyrimidine nucleoside derived organopalladium intermediates was investigated.The organopalladium intermediates were generated in situ by the reaction of 5-(chloromercuri)-2'-deoxyuridine (1), 5-(chloromercuri)cytidine, and 5-(chloromercuri)-2'-deoxycytidine with a catalytic amount of Li2PdCl4 in methanol.With allyl chloride, 1 gives principally 5-allyl-2'-deoxyuridine, some of which reacts further with 1 to give the cross-linked nucleosides (E)-5--2'-deoxyuridine (5) and5--2'-deoxyuridine (6). 3-Chloro-1-butene couples with 1 to give mainly (E)-5-(2-buten-1-yl)-2'-deoxyuridine (9) and lesser amounts of the Z isomer 10 and 5-(1-methyl-2-propen-1-yl)-2'-deoxyuridine (11).Nucleoside 11 appears to be the product of a coupling reaction between 1-methoxy-2-butene and the organopalladium intermediate derived from 1.Allylic chlorides are transformed to allyl methyl ethers in 0.1 M Li2PdCl4 at a slightly slower rate than the coupling reaction.Higher allylic chloride homologues show greater regioselectivity and stereoselectivity. 3-Chloro-1-pentene leads to (E)-5-(2-penten-1-yl)-2'-deoxyuridine (14) as the sole major product in 50percent yield.When a cyano group was attached to C-5 of 3-chloro-1-pentene, the resultant allylic chloride coupled regioselectivity but gave both cis and trans isomers.The mechanism of the coupling reaction is discussed and a basis for stereoselectivity proposed.Allylic alcohols and acetates couple more slowly and less cleanly, leading to lower yields of the same allylic-substituted pyrimidine nucleosides obtained with allylic chlorides.In some instances other products could be isolated.Nucleoside 1 and 3-hydroxy-4-methyl-1-pentene gave 5-(4-methyl-2-penten-1-yl)-2'-deoxyuridine (16) as well as 5-(4-methyl-3-oxopentyl)-2'-deoxyuridine (20). 3-Acetoxy-4-methyl-1-pentene led to (E)-5-(4-methyl-1,3-pentadien-1-yl)-2'-deoxyuridine (23).Mechanisms leading to these products are discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 73-39-2